In the case of Kaposi's sarcoma reported by Roy et al. [46], it is pointed out that mTOR inhibition is considered to be effective in the treatment of Kaposi's sarcoma because it inhibits angiogenesis by reducing the secretion of vascular endothelial growth factor and inhibiting the formation of tumor blood vessels. This evidence concerns the gene VEGFA and neoplasm.